Search clinical trials for: BMS-790052 (NS5A Inhibitor)
Total 1670 results
-
Bristol-Myers SquibbTerminatedStudy to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced MelanomaMelanomaFrance, United States, Italy, Germany, Austria
-
Jaime MerchanBristol-Myers Squibb; PfizerCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
CelgeneCompletedMultiple MyelomaBelgium, United Kingdom, Italy, Germany, Sweden, Denmark, Norway, Spain
-
University of PittsburghBristol-Myers SquibbCompletedMalignant Solid TumourUnited States
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Canada
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Syntrix Biosystems, Inc.RecruitingMetastatic Colon Adenocarcinoma | Metastatic Colorectal Carcinoma | Metastatic Rectal Adenocarcinoma | Stage III Colon Cancer AJCC v8 | Stage III Rectal Cancer AJCC v8 | Stage IIIA Colon Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Colon Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC... and other conditionsUnited States
-
Bristol-Myers SquibbCompletedLeukemiaGermany, Italy, Korea, Republic of, Sweden, Thailand, United States, Australia, France, Poland, Switzerland, Spain, Ireland, Peru, Brazil, South Africa, Canada, Argentina, Hungary, Finland, Israel, Norway, Russian Federation, United... and more
-
Bristol-Myers SquibbCompletedVascular DiseasesUnited States
-
Bristol-Myers SquibbCompleted
-
Dragonfly TherapeuticsRecruitingSolid TumorsUnited States, Spain, Australia, France
-
Bristol-Myers SquibbCompletedEsophageal Squamous Cell CarcinomaUnited Kingdom
-
Bristol-Myers SquibbCompletedMetastatic Colorectal Cancer (MCRC)United States, Italy, Korea, Republic of, Spain, Sweden, Argentina, Denmark
-
NYU Langone HealthRecruitingMelanoma | Unresectable MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation RecipientUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingVarious Advanced CancerUnited States, Japan, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Czechia, Denmark, France, Hong Kong, Italy, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Singapore, Spain, ... and more
-
H. Lee Moffitt Cancer Center and Research InstituteSecura Bio, Inc.Active, not recruitingHodgkin Lymphoma | Non Hodgkin Lymphoma | Myeloma | Lymphocytic LeukemiaUnited States
-
Jose Lutzky, MDBristol-Myers Squibb; United States Department of DefenseActive, not recruitingMetastatic Uveal MelanomaUnited States
-
Bristol-Myers SquibbOno Pharma USA IncCompletedRenal Cell CarcinomaUnited States, Canada, Italy, Finland
-
American University of Beirut Medical CenterBristol-Myers SquibbTerminatedCholangiocarcinomaLebanon, Belgium, Luxembourg
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbCompletedClear Cell Renal Cell CarcinomaUnited States
-
AstraZenecaBristol-Myers SquibbTerminated
-
Bristol-Myers SquibbMedarexCompletedAdvanced MelanomaUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
Dana-Farber Cancer InstituteBristol-Myers SquibbWithdrawnMelanoma Stage IV | Melanoma Stage IIIUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Bristol-Myers SquibbEuropean Organisation for Research and Treatment of Cancer - EORTCTerminatedGlioblastomaSwitzerland, Netherlands, Italy, France
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHepatocellular Carcinoma | Resectable Hepatocellular CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Accelerated Phase Chronic Myelogenous Leukemia | Childhood Chronic Myelogenous Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic... and other conditionsUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingNeoplasms | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Urinary Bladder Diseases | Male Urogenital Diseases | Female Urogenital Diseases | Urinary Bladder Neoplasm | Female Urogenital Diseases and Pregnancy Complications | Antineoplastics Toxicity | Urogenital DiseasesNetherlands
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbRecruitingSarcoma | Solid Tumor, Adult | Solid Tumor, ChildhoodUnited States
-
M.D. Anderson Cancer CenterMologen AGActive, not recruitingMelanoma | Advanced CancersUnited States
-
Bristol-Myers SquibbActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, France, Australia, Canada, Italy, Norway, Spain, Sweden, United Kingdom
-
PrECOG, LLC.Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedMelanomaGermany, Italy, Sweden, United Kingdom, Belgium, Netherlands, Spain, Finland, Austria, Ireland, Poland, Portugal, Russian Federation, Switzerland, Czechia, Greece, Hungary, Luxembourg, Norway, Romania
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedBladder CancerUnited States
-
University Hospital Southampton NHS Foundation...Bristol-Myers Squibb; Cancer Research UK; Institute of Cancer Research, United...CompletedExtensive Stage Small Cell Lung CancerUnited Kingdom
-
Bristol-Myers SquibbCompletedVenous Thrombosis | Pulmonary EmbolismArgentina, Australia, France, India, Korea, Republic of, United Kingdom, United States, Spain, Mexico, Colombia, Austria, Denmark, Canada, Germany, Israel, Peru, Singapore, Sweden, Poland, Belgium, Hungary, Italy, Russian Federation, ... and more
-
Washington University School of MedicineBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene MutationUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)TerminatedBreast Neoplasms | Triple Negative Breast NeoplasmsUnited States
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
National Cancer Institute (NCI)CompletedTongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous... and other conditionsUnited States
-
zr Pharma & GmbHBristol-Myers Squibb; Foundation MedicineTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Endometrioid Adenocarcinoma | High Grade Serous Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Bristol-Myers SquibbNo longer availableHIV InfectionsUnited States, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; ISA Pharmaceuticals B.V.CompletedSolid TumorsUnited States
-
Bristol-Myers SquibbCompletedMelanomaAustralia, France, Italy, Poland, United Kingdom, United States, Spain, Belgium, Denmark, Germany, Norway, Switzerland, Argentina, Austria, Sweden, Czechia, Hungary, Netherlands, Mexico, Canada, Israel, South Africa